Iovance Biotherapeutics Inc
F:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
Abionyx Pharma SA
F:609
|
FR |
|
C
|
Chargeurs SA
F:GET
|
FR |
|
Nano One Materials Corp
F:LBMB
|
CA |
|
O
|
Olin Corp
XMUN:OLN
|
US |
|
Globalstar Inc
F:P8S
|
US |
|
V
|
Volkswagen AG
DUS:VOW
|
DE |
|
U
|
Unisys Corp
SIX:UIS
|
US |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
T
|
Telefonaktiebolaget LM Ericsson
DUS:ERCB
|
SE |
|
C
|
California Water Service Group
F:WT5
|
US |
Shareholder Yield
Current shareholder yield for 
2LB is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2LB Price
Iovance Biotherapeutics Inc
| Average Annual Return | -7.63% |
| Standard Deviation of Annual Returns | 39.42% |
| Max Drawdown | -94% |
| Market Capitalization | 1.9B EUR |
| Shares Outstanding | 279 832 992 |
| Percentage of Shares Shorted |
N/A
|
